# A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief

> **NCT03514277** · PHASE4 · TERMINATED · sponsor: **Virtua Health, Inc.** · enrollment: 19 (actual)

## Conditions studied

- Low Back Pain
- Lumbosacral Radiculopathy
- Lumbar Disc Degeneration
- Lumbar Disc Herniation
- Stenosis
- Spondylolisthesis
- Spondylolysis
- Deformity of Spine

## Interventions

- **DRUG:** Exparel
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT03514277
- **Lead sponsor:** Virtua Health, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** PI decision to close study early
- **Last updated:** 2021-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03514277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03514277, "A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03514277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*